ALL vs RNXT · P/E 4.9, $56.89B cap vs rev $266.0K
The Allstate Corporation (ALL) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the ALL and RNXT stock pages for the full models.
Not investment advice.